BRIEF-Xintela participates in gov. funded initiative to form cell, gene therapy research center – Reuters
|
BRIEF-Xintela participates in gov. funded initiative to form cell, gene therapy research center
Reuters Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world’s largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news … |
|
BRIEF-Xintela participates in gov. funded initiative to form cell, gene therapy research center
Reuters Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world’s largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news … |
|
BRIEF-Xintela participates in gov. funded initiative to form cell, gene therapy research center
Reuters Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world’s largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news … |
Genetic Literacy Project |
CRISPR Could Point to a Cure For Huntington’s Disease, Suggests New Study
ScienceAlert If you’re completely new to CRISPR, or clustered regularly interspaced short palindromic repeats, it enables scientists to “cut and paste” DNA data with great accuracy. Cas9 refers to one particular way of using CRISPR that’s currently being explored. Reversing Huntington’s? Brain shown to heal itself after disease source edited out — in miceGenetic Literacy Project |
|
CRISPR Could Point to a Cure For Huntington’s Disease, Suggests New Study
ScienceAlert We’ve seen how CRISPR/Cas9 can be used to tackle HIV and cancer, and now the revolutionary gene editing technique has Huntington’s disease in its sights, as scientists have used it to reverse signs of the condition in mice. That suggests CRISPR/Cas9 … |
Lincolnshire Echo |
‘Fantastic’ response to Sleaford soldier Myles Brown’s stem cell donor quest
Lincolnshire Echo A charity says it has received a “fantastic” response to an appeal to find a potential stem cell donor to help Sleaford soldier Myles Brown who is fighting cancer. Private Brown, 27, has been diagnosed with acute lymphoblastic leukaemia – a cancer that … |
|
First-line immunotherapy treatment can improve survival for subset of lung cancer patients
Science Daily In this study, researchers compared the effectiveness of the immunotherapy drug nivolumab (pronounced “nye VOL ue mab,” marketed at Opdivo), with standard-of-care chemotherapy in 541 patients with previously untreated or recurrent non-small cell lung … |